ZVRA
Zevra Therapeutics Inc.
10.70$
+0.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +17.1% | +11.3% | +177.3% | – | |
| – | +1,169.4% | +98.5% | +0.0% | +3.5% | +1.9% | +0.1% | +0.1% | -76.3% | -7.7% | +1.7% | -1.1% | – | |
| – | +107.1% | -26.2% | +24.2% | +133.2% | -34.5% | -22.5% | -20.9% | +12.5% | +54.6% | -27.5% | -4.4% | – | |
| – | -140.2% | – | – | – | – | -474.6% | – | – | – | – | -109.7% | – | |
| – | -58.1% | +0.0% | -100.0% | – | – | – | +115.2% | +160.1% | -94.4% | +12.9% | +520.0% | – | |
| – | – | – | -100.9% | +24,205.4% | -82.6% | – | +13.2% | -138.3% | – | +34,974.0% | -60.5% | – | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | -80.9% | -75.7% | +1,159.7% | +322.5% | -98.8% | +101.9% | -14.1% | +372.8% | -61.0% | -2,174.0% | – | – | |
| – | – | – | – | – | -237.0% | – | +191.8% | -35.1% | +18.4% | +316.6% | +49.8% | – | |
| – | – | – | – | – | – | – | – | – | +33.5% | +10.1% | +175.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.